fadrozole has been researched along with abiraterone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartmann, RW; Hu, Q; Kazmaier, U; Lucas, S; Maurer, F; Yin, L | 1 |
| Belluti, F; Bisi, A; Gobbi, S; Hartmann, RW; Hu, Q; Negri, M; Rampa, A; Zimmer, C | 1 |
| Engel, M; Hartmann, RW; Hu, Q; Pinto-Bazurco Mendieta, MA | 1 |
3 other study(ies) available for fadrozole and abiraterone
| Article | Year |
|---|---|
Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndrome.
Topics: Animals; Aromatase; Cushing Syndrome; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Humans; Imidazoles; Inhibitory Concentration 50; Quinolones; Rats; Stereoisomerism; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase; Substrate Specificity | 2012 |
Modulation of cytochromes P450 with xanthone-based molecules: from aromatase to aldosterone synthase and steroid 11β-hydroxylase inhibition.
Topics: Animals; Aromatase Inhibitors; Cricetinae; Cytochrome P-450 CYP11B2; Fibroblasts; Humans; Imidazoles; Models, Molecular; Small Molecule Libraries; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase; Structure-Activity Relationship; Xanthones | 2013 |
Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseases.
Topics: Antineoplastic Agents; Cardiovascular Diseases; Cell Line; Cytochrome P-450 CYP11B2; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Humans; Male; Models, Molecular; Naphthalenes; Prostatic Neoplasms; Pyridines; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase | 2013 |